XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Shareholders' (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Related Party [Member]
Common Stock Including Additional Paid in Capital [Member]
Related Party [Member]
Retained Earnings [Member]
Related Party [Member]
Common Stock [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Feb. 03, 2024       12,926,022      
Balance at Feb. 03, 2024         $ 176,552 $ (173,428) $ 3,124
Restricted stock issued (in shares)       134,597      
Restricted stock issued         0 0 0
Net share settlement of restricted stock units (in shares)       (21,641)      
Net share settlement of restricted stock units         (51) 0 (51)
Stock-based compensation expense         292 0 292
Net loss         0 (8,830) (8,830)
Balance (in shares) at May. 04, 2024       13,038,978      
Balance at May. 04, 2024         176,793 (182,258) (5,465)
Balance (in shares) at Feb. 03, 2024       12,926,022      
Balance at Feb. 03, 2024         176,552 (173,428) 3,124
Net loss             (23,334)
Balance (in shares) at Aug. 03, 2024       13,111,638      
Balance at Aug. 03, 2024         177,057 (196,762) (19,705)
Balance (in shares) at May. 04, 2024       13,038,978      
Balance at May. 04, 2024         176,793 (182,258) (5,465)
Restricted stock issued (in shares)       72,660      
Restricted stock issued         0 0 0
Stock-based compensation expense         264 0 264
Net loss         0 (14,504) (14,504)
Balance (in shares) at Aug. 03, 2024       13,111,638      
Balance at Aug. 03, 2024         177,057 (196,762) (19,705)
Balance (in shares) at Feb. 01, 2025       13,117,942      
Balance at Feb. 01, 2025         177,543 (196,560) (19,017)
Restricted stock issued (in shares)       131,006      
Restricted stock issued         0 0 0
Net share settlement of restricted stock units (in shares)       (39,200)      
Net share settlement of restricted stock units         (51) 0 (51)
Issuance of common stock to Bed Bath & Beyond, Inc. for subscription agreement (in shares)       4,324,324      
Issuance of common stock to Bed Bath & Beyond, Inc. for subscription agreement         7,730 0 7,730
Issuance of common stock to Bed Bath & Beyond, Inc. to convert term loan and accrued interest (in shares)       4,610,141      
Issuance of common stock to Bed Bath & Beyond, Inc. to convert term loan and accrued interest         6,705 0 6,705
Issuance of common stock for payment of equity issuance costs (in shares)       310,135      
Stock-based compensation expense         239 0 239
Net loss         0 (11,824) (11,824)
Balance (in shares) at May. 03, 2025       22,454,348      
Balance at May. 03, 2025         192,166 (208,384) (16,218)
Balance (in shares) at Feb. 01, 2025       13,117,942      
Balance at Feb. 01, 2025         177,543 (196,560) (19,017)
Net loss             (32,003)
Balance (in shares) at Aug. 02, 2025       22,461,383      
Balance at Aug. 02, 2025         193,402 (228,563) (35,161)
Balance (in shares) at May. 03, 2025       22,454,348      
Balance at May. 03, 2025         192,166 (208,384) (16,218)
Restricted stock issued (in shares)       10,000      
Restricted stock issued         0 0 0
Net share settlement of restricted stock units (in shares)       (2,965)      
Net share settlement of restricted stock units         (4) 0 (4)
Stock-based compensation expense         82 0 82
Net loss         0 (20,179) (20,179)
Gain on debt extinguishment from a related party $ 1,158 $ 0 $ 1,158        
Balance (in shares) at Aug. 02, 2025       22,461,383      
Balance at Aug. 02, 2025         $ 193,402 $ (228,563) $ (35,161)